Desang diabetes magazine, diabetes news

8

NEWS

T2D and

other risks

There are good reasons to try to

control T2D by weight loss. The

biggest study to date, involving

3m people with an average age

of 50, compared health data

of people with T2D and those

without. Professor Emanuele Di

Angelantonio from Cambridge

University, who led the project,

looked at 116 chronic long-term

illnesses and found people with T2D

typically developed 'middle-aged

health problems' five years earlier

than those without the condition.

Personalised care for T2D

The drive towards personalised care continues with the development of new

software called the Healum app. Results of an 18-month trial presented at

the Diabetes UK professional conference in March showed people who used

it had an average 9.5% reduction in HbA1c blood glucose compared with

2% reduction in a comparable control group. "A key challenge in long-term

condition management is to motivate and support patients to make healthy

choices and understand how to best manage their diabetes in a way that

means something to them," said Dr. Adrian Heald, a diabetes specialist from

Salford Royal Hospital, who led the National Institute of Health Researchfunded

study in Manchester. The app has so far been trialled in just 36

volunteers and the aim is now to collect data from a further 214 people to see

how it can best be adjusted and refined.

The app has been developed by the co-founders of Healum, Anuj Saboo

and Jonathan Abraham. They worked collaboratively with diabetes clinicians

throughout the project, helping to inform the design of the product so it can

work as a truly assistive technology to make doctors lives easier, and improve

outcomes for patients.

For more info on the trial, CLICK HERE.

Novo Nordisk smart pens

NovoPen® 6 and NovoPen Echo® Plus

are a new generation of insulin pens

that record dosing information over a

period of time. They are now available

to people living with diabetes on NHS

prescription.

People living with Type 1 diabetes

experienced a reduction in time spent

in hyperglycaemia and missed fewer

bolus injections, when using NovoPen

6 in an observational study.

Both models are reusable,

reducing their environmental impact,

in line with the company's Circular

for Zero environmental strategy.

The smart pens are insulin

injection pens that record dosing

information, including when and

how much insulin was administered.

This data can be uploaded to a

compatible app and viewed by

people living with diabetes and their

healthcare professionals. Currently,

insulin injection dosing information

is manually recorded in a log book

or app. However, in clinical practice,

incomplete or inaccurate information

on insulin dosing and timing can be

a significant barrier to optimising

glycaemic control.

NovoPen 6 and NovoPen Echo Plus

can allow healthcare professionals

to view their patient's insulin dosing

information, helping to facilitate

more productive consultations and

support personalised treatment

guidance. Remote access to this data

may also help to support a longerterm transition

from in-person to

virtual care, during and after the

Covid-19 pandemic, which could

also help alleviate pressure on health

system capacity.

Emma Wilmot, Consultant

Diabetologist, University Hospitals of

Derby and Burton NHS Foundation

Trust says of the innovation,

"Integrating innovative technology

as a routine part of diabetes care

is an important step to improve

diabetes care. Novo Nordisk's smart

connected pens are an example of

how technology can support people

living with diabetes to gain greater

insight into the management of

their diabetes, on their journey to

becoming experts in their diabetes.

In my clinic, the opportunity to view

daily insulin data will allow me to

better support the individual with

diabetes to achieve their goals. It will

allow for more tailored and informed

advice on optimisation of glucose

levels, with the ultimate goal of

improving future outcomes."

Results from an observational

study indicate that using NovoPen 6

to administer their insulin could give

people living with Type 1 diabetes

close to two extra hours of improved

glucose levels per day, with a

reduction in time spent in hyper- and

hypoglycaemia. A further analysis

looking at missed bolus doses (insulin

that is specifically taken at mealtimes)

indicated that NovoPen 6 decreased

the average daily number of missed

doses by 43% by the end of the study.

Index

  1. Free online Desang diabetes magazine, diabetes information
  2. Free online Desang diabetes magazine, diabetes information
  3. Free online Desang diabetes magazine, diabetes information
  4. Desang diabetes magazine, diabetes news
  5. insulin pump, Dana i system, artificial pancreas, Advanced Therapeutics UK, CamAPS FX, Dexcom G6
  6. Desang diabetes magazine, diabetes news
  7. Abbott Freestyle Libre 2, Flash Glucose Monitoring, FSL2
  8. Desang diabetes magazine, diabetes news
  9. Glooko diabetes data download software. Stay on track in between visits.
  10. Page 0010
  11. Air Liquide Healthcare UK, Tandem t:slim insulin pump with Control IQ
  12. Desang diabetes magazine article on new NICE guidelines April 2022 spur far wider access to diabetes
  13. Home test HbA1c, A1C Now Self-Check
  14. Desang diabetes magazine article on new NICE guidelines April 2022 spur far wider access to diabetes
  15. Medtrum Touchcare Nano Patch Pump and CGM
  16. Diabetes technology, CGM sensors, FreeStyle Libre, Dexcom One, Glucorx Aidex CGM
  17. Diabetes technology, CGM sensors, FreeStyle Libre, Dexcom One, Glucorx Aidex CGM
  18. New drugs to replace insulin, replacing or preserving beta cells in people with type 1 diabetes.
  19. New drugs to replace insulin, replacing or preserving beta cells in people with type 1 diabetes.
  20. Stem cells and gene editing for a cure to Type 1 diabetes.
  21. Medtronic MiniMed 780G System Automated for an easier way to stabilise glucose levels
  22. Page 0022
  23. Stem cells and gene editing for a cure to Type 1 diabetes.
  24. Desang Diabetes Magazine, free diabetes magazine, living with diabetes
  25. Desang Diabetes Magazine, free diabetes magazine, living with diabetes
  26. JDRF's pathway to choice project for accdss to diabetes technology.
  27. JDRF's pathway to choice project for accdss to diabetes technology.
  28. Desang diabetes magazine, diabetes diet
  29. Diabetes technology education from Diabetes Technology Network DTN
  30. Desang diabetes magazine, diabetes diet
  31. Insulet Omnipod DASH insulin pump with insulin pods, podders, Omnipod DASH Personal Diabetes Manager
  32. Desang diabetes magazine, diabetes diet
  33. Desang diabetes magazine, diabetes diet
  34. Desang Diabetes Magazine, Making Carbs Count, carbohydrate counting for diabetes
  35. Making Carbs Count, Carbohydrate counting for diabetes, Desang diabetes magazine
  36. Making Carbs Count, Carbohydrate counting for diabetes, Desang diabetes magazine
  37. Desang diabetes kitbags, bag for diabetes kit
  38. Desang Diabetes Magazine, free diabetes magazine, living with diabetes

Related Issues